207 related articles for article (PubMed ID: 22531913)
1. Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection.
Schmitz N; Beerli RR; Bauer M; Jegerlehner A; Dietmeier K; Maudrich M; Pumpens P; Saudan P; Bachmann MF
Eur J Immunol; 2012 Apr; 42(4):863-9. PubMed ID: 22531913
[TBL] [Abstract][Full Text] [Related]
2. Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.
El Bakkouri K; Descamps F; De Filette M; Smet A; Festjens E; Birkett A; Van Rooijen N; Verbeek S; Fiers W; Saelens X
J Immunol; 2011 Jan; 186(2):1022-31. PubMed ID: 21169548
[TBL] [Abstract][Full Text] [Related]
3. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
5. Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
Geeraedts F; ter Veer W; Wilschut J; Huckriede A; de Haan A
Vaccine; 2012 Oct; 30(45):6501-7. PubMed ID: 22841974
[TBL] [Abstract][Full Text] [Related]
6. Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies.
De Filette M; Martens W; Smet A; Schotsaert M; Birkett A; Londoño-Arcila P; Fiers W; Saelens X
Vaccine; 2008 Dec; 26(51):6503-7. PubMed ID: 18835315
[TBL] [Abstract][Full Text] [Related]
7. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
[TBL] [Abstract][Full Text] [Related]
8. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
[TBL] [Abstract][Full Text] [Related]
10. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
Wu F; Yuan XY; Huang WS; Chen YH
Vaccine; 2009 Oct; 27(43):6095-101. PubMed ID: 19056447
[TBL] [Abstract][Full Text] [Related]
11. TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.
Jeisy-Scott V; Kim JH; Davis WG; Cao W; Katz JM; Sambhara S
J Virol; 2012 Oct; 86(20):10988-98. PubMed ID: 22837197
[TBL] [Abstract][Full Text] [Related]
12. Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis.
Ato M; Takahashi Y; Fujii H; Hashimoto S; Kaji T; Itamura S; Horiuchi Y; Arakawa Y; Tashiro M; Takemori T
Vaccine; 2013 Apr; 31(17):2184-90. PubMed ID: 23434386
[TBL] [Abstract][Full Text] [Related]
13. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
14. Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
Rappazzo CG; Watkins HC; Guarino CM; Chau A; Lopez JL; DeLisa MP; Leifer CA; Whittaker GR; Putnam D
Vaccine; 2016 Mar; 34(10):1252-8. PubMed ID: 26827663
[TBL] [Abstract][Full Text] [Related]
15. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
Jazi MH; Dabaghian M; Tebianian M; Gharagozlou MJ; Ebrahimi SM
Virus Res; 2012 Aug; 167(2):219-25. PubMed ID: 22609252
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
Liu W; Zou P; Chen YH
Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
[TBL] [Abstract][Full Text] [Related]
17. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.
Fan J; Liang X; Horton MS; Perry HC; Citron MP; Heidecker GJ; Fu TM; Joyce J; Przysiecki CT; Keller PM; Garsky VM; Ionescu R; Rippeon Y; Shi L; Chastain MA; Condra JH; Davies ME; Liao J; Emini EA; Shiver JW
Vaccine; 2004 Aug; 22(23-24):2993-3003. PubMed ID: 15297047
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
Lo CY; Wu Z; Misplon JA; Price GE; Pappas C; Kong WP; Tumpey TM; Epstein SL
Vaccine; 2008 Apr; 26(17):2062-72. PubMed ID: 18378366
[TBL] [Abstract][Full Text] [Related]
19. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
20. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
